Published in PLoS One on March 05, 2013
Autophagy regulates the therapeutic potential of mesenchymal stem cells in experimental autoimmune encephalomyelitis. Autophagy (2014) 0.90
Low-dose bone morphogenetic protein-2/stromal cell-derived factor-1β cotherapy induces bone regeneration in critical-size rat calvarial defects. Tissue Eng Part A (2014) 0.87
Platelet rich plasma clot releasate preconditioning induced PI3K/AKT/NFκB signaling enhances survival and regenerative function of rat bone marrow mesenchymal stem cells in hostile microenvironments. Stem Cells Dev (2013) 0.86
Administration of BMSCs with muscone in rats with gentamicin-induced AKI improves their therapeutic efficacy. PLoS One (2014) 0.81
Rapamycin up-regulation of autophagy reduces infarct size and improves outcomes in both permanent MCAL, and embolic MCAO, murine models of stroke. Exp Transl Stroke Med (2014) 0.81
Mesenchymal stem cell expression of SDF-1β synergizes with BMP-2 to augment cell-mediated healing of critical-sized mouse calvarial defects. J Tissue Eng Regen Med (2015) 0.78
Heat shock pretreatment improves stem cell repair following ischemia-reperfusion injury via autophagy. World J Gastroenterol (2015) 0.77
Total body irradiation is permissive for mesenchymal stem cell-mediated new bone formation following local transplantation. Tissue Eng Part A (2014) 0.77
Genetic Engineering of Mesenchymal Stem Cells to Induce Their Migration and Survival. Stem Cells Int (2016) 0.77
Caloric restriction and the adipokine leptin alter the SDF-1 signaling axis in bone marrow and in bone marrow derived mesenchymal stem cells. Mol Cell Endocrinol (2015) 0.77
Stromal cell-derived factor-1 promotes human adipose tissue-derived stem cell survival and chronic wound healing. Exp Ther Med (2016) 0.76
Enhanced Autophagy of Adipose-Derived Stem Cells Grown on Chitosan Substrates. Biores Open Access (2015) 0.76
Mesenchymal stem cell expression of stromal cell-derived factor-1β augments bone formation in a model of local regenerative therapy. J Orthop Res (2014) 0.76
Mesenchymal Stromal Cells Deficient in Autophagy Proteins are Susceptible to Oxidative Injury and Mitochondrial Dysfunction. Am J Respir Cell Mol Biol (2016) 0.75
Autophagy Inhibition Delays Early but Not Late-Stage Metastatic Disease. J Pharmacol Exp Ther (2016) 0.75
Association of Plasma SDF-1 with Bone Mineral Density, Body Composition, and Hip Fractures in Older Adults: The Cardiovascular Health Study. Calcif Tissue Int (2017) 0.75
Cell death: critical control points. Cell (2004) 22.56
Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol (2007) 15.47
Autophagy in health and disease: a double-edged sword. Science (2004) 13.69
Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1. EMBO J (2007) 11.72
Potential therapeutic applications of autophagy. Nat Rev Drug Discov (2007) 8.56
A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc Natl Acad Sci U S A (1996) 8.53
Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med (2003) 8.46
Emerging roles of caspase-3 in apoptosis. Cell Death Differ (1999) 8.05
Autophagic cell death: the story of a misnomer. Nat Rev Mol Cell Biol (2008) 6.78
LC3 conjugation system in mammalian autophagy. Int J Biochem Cell Biol (2004) 6.34
Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci U S A (2002) 6.05
CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J Biol Chem (1994) 5.51
CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin Cancer Res (2010) 5.42
Why are MSCs therapeutic? New data: new insight. J Pathol (2009) 5.25
Crystal structure of the Bcl-XL-Beclin 1 peptide complex: Beclin 1 is a novel BH3-only protein. J Biol Chem (2007) 5.21
Response to myocardial ischemia/reperfusion injury involves Bnip3 and autophagy. Cell Death Differ (2006) 4.29
CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol (2004) 4.08
Apoptotic pathways: ten minutes to dead. Cell (2005) 3.96
Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Proc Natl Acad Sci U S A (1998) 3.17
Adult stem cells for tissue repair - a new therapeutic concept? N Engl J Med (2003) 3.15
BH3-only proteins and BH3 mimetics induce autophagy by competitively disrupting the interaction between Beclin 1 and Bcl-2/Bcl-X(L). Autophagy (2007) 3.08
Pivotal role of the cell death factor BNIP3 in ceramide-induced autophagic cell death in malignant glioma cells. Cancer Res (2004) 2.78
A genome-wide siRNA screen reveals multiple mTORC1 independent signaling pathways regulating autophagy under normal nutritional conditions. Dev Cell (2010) 2.40
Studying gene function in eukaryotes by conditional gene inactivation. Annu Rev Genet (2002) 2.20
Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells. Blood (2005) 2.13
Stem cells associated with macroporous bioceramics for long bone repair: 6- to 7-year outcome of a pilot clinical study. Tissue Eng (2007) 2.10
Hematopoietic cells and osteoblasts are derived from a common marrow progenitor after bone marrow transplantation. Proc Natl Acad Sci U S A (2004) 1.82
Stromal cell-derived factor-1/CXCL12 directly enhances survival/antiapoptosis of myeloid progenitor cells through CXCR4 and G(alpha)i proteins and enhances engraftment of competitive, repopulating stem cells. J Leukoc Biol (2003) 1.80
Differential processing of stromal-derived factor-1alpha and stromal-derived factor-1beta explains functional diversity. Blood (2003) 1.72
Diverse transcriptional response of CD4+ T cells to stromal cell-derived factor SDF-1: cell survival promotion and priming effects of SDF-1 on CD4+ T cells. J Immunol (2001) 1.70
Osteoblast-specific gene expression after transplantation of marrow cells: implications for skeletal gene therapy. Proc Natl Acad Sci U S A (1999) 1.53
Cells capable of bone production engraft from whole bone marrow transplants in nonablated mice. J Exp Med (1999) 1.51
hvps34, an ancient player, enters a growing game: mTOR Complex1/S6K1 signaling. Curr Opin Cell Biol (2007) 1.45
Regulation of mesenchymal stem cell osteogenic differentiation by glucocorticoid-induced leucine zipper (GILZ). J Biol Chem (2007) 1.28
Identification of carboxypeptidase N as an enzyme responsible for C-terminal cleavage of stromal cell-derived factor-1alpha in the circulation. Blood (2005) 1.27
SDF-1/CXCR4 axis modulates bone marrow mesenchymal stem cell apoptosis, migration and cytokine secretion. Protein Cell (2011) 1.27
Autophagy activation: a novel mechanism of atorvastatin to protect mesenchymal stem cells from hypoxia and serum deprivation via AMP-activated protein kinase/mammalian target of rapamycin pathway. Stem Cells Dev (2012) 1.25
Netrin-1 prevents ischemia/reperfusion-induced myocardial infarction via a DCC/ERK1/2/eNOS s1177/NO/DCC feed-forward mechanism. J Mol Cell Cardiol (2010) 1.24
Age-related changes in the osteogenic differentiation potential of mouse bone marrow stromal cells. J Bone Miner Res (2008) 1.23
Fibroblast growth factor-2 and -4 promote the proliferation of bone marrow mesenchymal stem cells by the activation of the PI3K-Akt and ERK1/2 signaling pathways. Stem Cells Dev (2008) 1.20
Initiation of apoptosis and autophagy by the Bcl-2 antagonist HA14-1. Cancer Lett (2006) 1.10
Carboxypeptidase M expressed by human bone marrow cells cleaves the C-terminal lysine of stromal cell-derived factor-1alpha: another player in hematopoietic stem/progenitor cell mobilization? Stem Cells (2008) 1.10
Lovastatin protects mesenchymal stem cells against hypoxia- and serum deprivation-induced apoptosis by activation of PI3K/Akt and ERK1/2. J Cell Biochem (2008) 1.07
Stromal cell-derived factor-1β potentiates bone morphogenetic protein-2-stimulated osteoinduction of genetically engineered bone marrow-derived mesenchymal stem cells in vitro. Tissue Eng Part A (2012) 1.02
Basal autophagy decreased during the differentiation of human adult mesenchymal stem cells. Stem Cells Dev (2012) 0.99
Increased SCF/c-kit by hypoxia promotes autophagy of human placental chorionic plate-derived mesenchymal stem cells via regulating the phosphorylation of mTOR. J Cell Biochem (2013) 0.90
Remote ischemic perconditioning is effective alone and in combination with intravenous tissue-type plasminogen activator in murine model of embolic stroke. Stroke (2012) 2.46
Is adiposity advantageous for bone strength? A peripheral quantitative computed tomography study in late adolescent females. Am J Clin Nutr (2007) 2.33
GADD34-PP1c recruited by Smad7 dephosphorylates TGFbeta type I receptor. J Cell Biol (2004) 1.98
Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria. J Biol Chem (2004) 1.79
Hematopoietic origin of microglial and perivascular cells in brain. Exp Neurol (2004) 1.75
Protein nitration impairs the myogenic tone of rat middle cerebral arteries in both ischemic and nonischemic hemispheres after ischemic stroke. Am J Physiol Heart Circ Physiol (2013) 1.74
Type 2 diabetes causes remodeling of cerebrovasculature via differential regulation of matrix metalloproteinases and collagen synthesis: role of endothelin-1. Diabetes (2005) 1.74
Blood pressure lowering after experimental cerebral ischemia provides neurovascular protection. J Hypertens (2007) 1.71
Bone marrow as a source of endothelial cells and NeuN-expressing cells After stroke. Stroke (2002) 1.61
Ten months of exercise improves general and visceral adiposity, bone, and fitness in black girls. Obesity (Silver Spring) (2007) 1.57
Immunolocalization of myostatin (GDF-8) following musculoskeletal injury and the effects of exogenous myostatin on muscle and bone healing. J Histochem Cytochem (2012) 1.51
Low dose intravenous minocycline is neuroprotective after middle cerebral artery occlusion-reperfusion in rats. BMC Neurol (2004) 1.47
Age-related loss of muscle mass and bone strength in mice is associated with a decline in physical activity and serum leptin. Bone (2006) 1.45
The roles of vitamin D in skeletal muscle: form, function, and metabolism. Endocr Rev (2012) 1.44
Jab1 antagonizes TGF-beta signaling by inducing Smad4 degradation. EMBO Rep (2002) 1.42
The neuroblast and angioblast chemotaxic factor SDF-1 (CXCL12) expression is briefly up regulated by reactive astrocytes in brain following neonatal hypoxic-ischemic injury. BMC Neurosci (2005) 1.38
Intrinsic hand proportions of euarchontans and other mammals: implications for the locomotor behavior of plesiadapiforms. J Hum Evol (2008) 1.34
ACTH protects against glucocorticoid-induced osteonecrosis of bone. Proc Natl Acad Sci U S A (2010) 1.26
Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells. J Clin Endocrinol Metab (2012) 1.25
Impact of transcendental meditation on ambulatory blood pressure in African-American adolescents. Am J Hypertens (2004) 1.25
Age-related changes in the osteogenic differentiation potential of mouse bone marrow stromal cells. J Bone Miner Res (2008) 1.23
Candesartan augments ischemia-induced proangiogenic state and results in sustained improvement after stroke. Stroke (2009) 1.23
Autoimmunity in Alzheimer's disease: increased levels of circulating IgGs binding Abeta and RAGE peptides. Neurobiol Aging (2004) 1.22
Caloric restriction decreases cortical bone mass but spares trabecular bone in the mouse skeleton: implications for the regulation of bone mass by body weight. J Bone Miner Res (2008) 1.20
Myostatin (GDF-8) deficiency increases fracture callus size, Sox-5 expression, and callus bone volume. Bone (2008) 1.17
Hypertension after experimental cerebral ischemia: candesartan provides neurovascular protection. J Hypertens (2006) 1.17
Hematopoietic origin of glomerular mesangial cells. Blood (2002) 1.17
Safety and efficacy of a xenogeneic DNA vaccine encoding for human tyrosinase as adjunctive treatment for oral malignant melanoma in dogs following surgical excision of the primary tumor. Am J Vet Res (2011) 1.17
Relationship of visceral adiposity to cardiovascular disease risk factors in black and white teens. Obesity (Silver Spring) (2007) 1.15
Cost-effectiveness of a school-based obesity prevention program. J Sch Health (2008) 1.14
SUMO wrestling with type 1 diabetes. J Mol Med (Berl) (2005) 1.13
An environmental approach to obesity prevention in children: Medical College of Georgia FitKid Project year 1 results. Obes Res (2005) 1.13
The adipokine leptin increases skeletal muscle mass and significantly alters skeletal muscle miRNA expression profile in aged mice. Biochem Biophys Res Commun (2010) 1.13
Disordered osteoclast formation in RAGE-deficient mouse establishes an essential role for RAGE in diabetes related bone loss. Biochem Biophys Res Commun (2005) 1.11
Smad4 protein stability is regulated by ubiquitin ligase SCF beta-TrCP1. J Biol Chem (2004) 1.11
Effect of neutrophil depletion on gelatinase expression, edema formation and hemorrhagic transformation after focal ischemic stroke. BMC Neurosci (2005) 1.11
Genistein decreases food intake, body weight, and fat pad weight and causes adipose tissue apoptosis in ovariectomized female mice. J Nutr (2006) 1.10
Vascular protection by angiotensin receptor antagonism involves differential VEGF expression in both hemispheres after experimental stroke. PLoS One (2011) 1.10
Vascular protection in diabetic stroke: role of matrix metalloprotease-dependent vascular remodeling. J Cereb Blood Flow Metab (2010) 1.10
Neurovascular injury in acute hyperglycemia and diabetes: A comparative analysis in experimental stroke. Transl Stroke Res (2011) 1.08
Vascular protection with candesartan after experimental acute stroke in hypertensive rats: a dose-response study. J Pharmacol Exp Ther (2008) 1.08
Effects of glucose-dependent insulinotropic peptide on osteoclast function. Am J Physiol Endocrinol Metab (2006) 1.08
Targets of vascular protection in acute ischemic stroke differ in type 2 diabetes. Am J Physiol Heart Circ Physiol (2013) 1.07
Sex-independent neuroprotection with minocycline after experimental thromboembolic stroke. Exp Transl Stroke Med (2011) 1.07
Heart rate variability in adolescents: relations to physical activity, fitness, and adiposity. Med Sci Sports Exerc (2005) 1.05
a Novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type III. J Clin Endocrinol Metab (2013) 1.05
Differential effects of ET(A) and ET(B) receptor antagonism on oxidative stress in type 2 diabetes. Vascul Pharmacol (2007) 1.04
Glucose-dependent insulinotropic polypeptide receptor knockout mice have altered bone turnover. Bone (2005) 1.03
Preparation and immunological effectiveness of a swine influenza DNA vaccine encapsulated in chitosan nanoparticles. Vaccine (2011) 1.02
Stromal cell-derived factor-1β potentiates bone morphogenetic protein-2-stimulated osteoinduction of genetically engineered bone marrow-derived mesenchymal stem cells in vitro. Tissue Eng Part A (2012) 1.02
Glucose-dependent insulinotropic peptide-overexpressing transgenic mice have increased bone mass. Bone (2007) 1.01
Identification of a conserved B-cell epitope on reticuloendotheliosis virus envelope protein by screening a phage-displayed random peptide library. PLoS One (2012) 1.01
Differential effects of haloperidol, risperidone, and clozapine exposure on cholinergic markers and spatial learning performance in rats. Neuropsychopharmacology (2002) 1.01
Multiple melanocortin receptors are expressed in bone cells. Bone (2005) 1.00
Single slice method for quantification of hemorrhagic transformation using direct ELISA. Neurol Res (2004) 1.00
Early atorvastatin reduces hemorrhage after acute cerebral ischemia in diabetic rats. J Pharmacol Exp Ther (2009) 0.99
Restoration of regenerative osteoblastogenesis in aged mice: modulation of TNF. J Bone Miner Res (2010) 0.97
Endothelin antagonism prevents early EGFR transactivation but not increased matrix metalloproteinase activity in diabetes. Am J Physiol Regul Integr Comp Physiol (2005) 0.97
High glucose augments the angiotensin II-induced activation of JAK2 in vascular smooth muscle cells via the polyol pathway. J Biol Chem (2003) 0.97
Effect of whole-body vibration on bone properties in aging mice. Bone (2010) 0.97
Impact of glucose-dependent insulinotropic peptide on age-induced bone loss. J Bone Miner Res (2008) 0.96
Reproducibility of ambulatory blood pressure measures in African-American adolescents. Ethn Dis (2002) 0.96
Heme oxygenase-1 induction contributes to renoprotection by G-CSF during rhabdomyolysis-associated acute kidney injury. Am J Physiol Renal Physiol (2011) 0.96
Biomineralization and adaptive plasticity of the temporomandibular joint in myostatin knockout mice. Arch Oral Biol (2005) 0.96
Evidence for vasculoprotective effects of ETB receptors in resistance artery remodeling in diabetes. Diabetes (2007) 0.95
Acute treatment with candesartan reduces early injury after permanent middle cerebral artery occlusion. Transl Stroke Res (2011) 0.94
Remote ischemic perconditioning is effective after embolic stroke in ovariectomized female mice. Transl Stroke Res (2014) 0.94
Alterations of temporalis muscle contractile force and histological content from the myostatin and Mdx deficient mouse. Arch Oral Biol (2005) 0.93
The impact of a 3-year after-school obesity prevention program in elementary school children. Child Obes (2012) 0.92
Plasticity of mandibular biomineralization in myostatin-deficient mice. J Morphol (2007) 0.92
Effects of glucose-dependent insulinotropic peptide on behavior. Peptides (2006) 0.91
Do bone marrow cells generate neurons? Arch Neurol (2004) 0.91
Effects of the activin A-myostatin-follistatin system on aging bone and muscle progenitor cells. Exp Gerontol (2012) 0.91
Absence of functional leptin receptor isoforms in the POUND (Lepr(db/lb)) mouse is associated with muscle atrophy and altered myoblast proliferation and differentiation. PLoS One (2013) 0.90
Muscle-bone interactions in dystrophin-deficient and myostatin-deficient mice. Anat Rec A Discov Mol Cell Evol Biol (2005) 0.90
A myostatin inhibitor (propeptide-Fc) increases muscle mass and muscle fiber size in aged mice but does not increase bone density or bone strength. Exp Gerontol (2013) 0.89
New hand bones of Hadropithecus stenognathus: implications for the paleobiology of the Archaeolemuridae. J Hum Evol (2008) 0.89
Comparisons of trabecular and cortical bone in late adolescent black and white females. J Bone Miner Metab (2010) 0.88
Low-dose bone morphogenetic protein-2/stromal cell-derived factor-1β cotherapy induces bone regeneration in critical-size rat calvarial defects. Tissue Eng Part A (2014) 0.87
Pituitary glycoprotein hormone receptors in non-endocrine organs. Trends Endocrinol Metab (2007) 0.86